Abivax S.A. ABVX
$73.20 −$7.45 (-9.24%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $74.95 +2.39%
Open$79.01
Prev close$80.65
Day range$62.70 – $79.74
Volume14.85M
Market cap$6.41B
P/E (TTM)–
Dividend yield–
ABVX Stock News
Headlines matching Abivax S.A. or the ABVX ticker, most recent first.
- Morgan Stanley Maintains Abivax S.A.(ABVX.US) With Buy Rating, Maintains Target Price $180
- A Quick Look at Today's Ratings for Abivax S.A.(ABVX.US), With a Forecast Between $118 to $180
- Abivax 1H Loss EUR165.9M ABVX Negative
- Goldman Sachs Initiates Abivax S.A.(ABVX.US) With Buy Rating, Announces Target Price $155
- Piper Sandler Maintains Abivax S.A.(ABVX.US) With Buy Rating, Raises Target Price to $175 Positive
- Morgan Stanley Maintains Abivax S.A.(ABVX.US) With Buy Rating, Raises Target Price to $180 Positive
- Truist Financial Maintains Abivax S.A.(ABVX.US) With Buy Rating, Announces Target Price $155
- Guggenheim Maintains Abivax S.A.(ABVX.US) With Buy Rating, Maintains Target Price $175
- Jefferies Maintains Abivax S.A.(ABVX.US) With Buy Rating, Maintains Target Price $158
- A Quick Look at Today's Ratings for Abivax S.A.(ABVX.US), With a Forecast Between $110 to $175
- Barclays Maintains Abivax S.A.(ABVX.US) With Buy Rating, Maintains Target Price $148
- Wolfe Research Maintains Abivax S.A.(ABVX.US) With Buy Rating, Cuts Target Price to $136 Negative
- Analysts Offer Insights on Healthcare Companies: HeartFlow, Inc. (HTFL), Taysha Gene Therapies (TSHA) and Abivax SA Sponsored ADR (ABVX)
- A Quick Look at Today's Ratings for Abivax S.A.(ABVX.US), With a Forecast Between $132 to $187
- Truist Financial Maintains Abivax S.A.(ABVX.US) With Buy Rating, Maintains Target Price $135
No comments yet — be the first to weigh in on ABVX.
Sign in to join the discussion.